Indus Medic Gas Profile
Key Indicators
- Authorised Capital ₹ 6.10 M
- Paid Up Capital ₹ 6.10 M
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.00 M
- Revenue Growth 6.93%
- Profit Growth -23.43%
- Ebitda 96.52%
- Net Worth -0.54%
- Total Assets -3.84%
About Indus Medic Gas
Indus Medic Gas Private Limited (IMGPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 October 2004 and has a history of 20 years and four months. Its registered office is in Palakkad, Kerala, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.10 M and a paid-up capital of Rs 6.10 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Abdul Pulath and Karalikattil Ummer serve as directors at the Company.
Company Details
-
Location
Palakkad, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U40200KL2004PTC017501
-
Company No.
017501
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Oct 2004
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Indus Medic Gas?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abdul Pulath | Managing Director | 02-Dec-2009 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Karalikattil Ummer | Director | 02-Dec-2009 | Current |
Financial Performance of Indus Medic Gas.
Indus Medic Gas Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 6.93% increase. The company also saw a substantial fall in profitability, with a 23.43% decrease in profit. The company's net worth dipped by a decrease of 0.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Indus Medic Gas?
In 2019, Indus Medic Gas had a promoter holding of 79.92% and a public holding of 20.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹8.00 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.80 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
01 Mar 2006 | Punjab National Bank | ₹8.00 M | Satisfied |
How Many Employees Work at Indus Medic Gas?
Unlock and access historical data on people associated with Indus Medic Gas, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indus Medic Gas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Medic Gas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.